31 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
2 Unknown  Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Conditions: Platelet Aggregation Inhibitors;   Coronary Heart Disease
Interventions: Drug: Clopidogrel;   Drug: Aspirin
3 Unknown  Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
4 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
5 Recruiting Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery
Conditions: Coronary Artery Bypass;   Antiplatelet Agents
Interventions: Drug: Aspirin;   Drug: Ticagrelor
6 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
7 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
8 Recruiting Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention:
9 Recruiting Ticagrelor and Endothelial Function
Condition: Antiplatelet Agents; Endothelial Function; Pleotropic Effects
Interventions: Drug: ticagrelor;   Drug: prasugrel
10 Unknown  BLeeding Events and Maintenance DoSe of PraSugrel
Conditions: Adverse Reaction to Antiplatelet Agent;   Acute Coronary Syndrome
Interventions: Drug: Prasugrel dose 5 mg/day;   Drug: Prasugrel dose 10 mg/day
11 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
12 Unknown  Platelet Transfusion in Acute Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Intervention: Biological: platelets
13 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
14 Unknown  Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel;   Drug: Prasugrel
15 Recruiting Platelet Function in Patients With an Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Intervention:
16 Not yet recruiting Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: ticagrelor
17 Recruiting Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy
18 Recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
19 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
20 Recruiting Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
Condition: Coronary Artery Disease
Interventions: Drug: Prasugrel;   Drug: Ticagrelor

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years